Bioalmanac
Ipamorelin
NNC 26-0161 · GHRP
A selective growth hormone secretagogue that prompts a short pulse of GH release. Widely used, and supported almost entirely by early pharmacology rather than outcome trials.
Storage
- Freeze-dried powder
- Refrigerated at 2–8 °C, protected from light.
- After mixing
- Refrigerated at 2–8 °C. Do not freeze once mixed.
- Long-term, frozen
- Unopened powder is stable at −20 °C or colder.
Reconstitution — 5 mg vial, 250 mcg dose
On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.
| Water added | Concentration | Volume to draw | Units | Doses per vial |
|---|---|---|---|---|
| 1 mL | 5 mg/mL | 0.05 mL | 5 units | 20 |
| 2 mL | 2.5 mg/mL | 0.1 mL | 10 units | 20 |
| 3 mL | 1.667 mg/mL | 0.15 mL | 15 units | 20 |
| 5 mL | 1 mg/mL | 0.25 mL | 25 units | 20 |
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Commonly described dose | 200–300 mcg | One to three times daily | Community practice |
| Before bed, commonly described | 200–300 mcg | Once daily at night | Community practice |
When to stop
- Numbness, tingling or pain in the hands or wrists that persists. This can indicate fluid-related nerve compression.
- Noticeable swelling in the hands, feet or face.
- Symptoms suggesting raised blood sugar: unusual thirst, frequent urination, or blurred vision. Growth hormone opposes insulin.
- Any new lump or growth. Growth hormone and IGF-1 promote cell proliferation, so this warrants prompt investigation rather than watching.
- Signs of infection at an injection site, or any allergic response. Seek urgent care for the latter.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.